7.01.22
7 min. Read

Apple-AliveCor. NightWare prescription count. Trials

Issue 156

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

 E&O Fridays.

Here's what's going on in FDA-regulated and pharma-focused digital

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
UnitedHealth’s Medicaid-Medicare plan covers Pear. Trials
10.07.22
6 min. Read
Big employer benefits analyses: AmerisourceBergen, Analog Devices
10.05.22
5 min. Read
Projecting Medicare, Medicaid spend on prescription digital therapeutics.
9.30.22
10 min. Read
AppleVR Alzheimer’s. Mahana freemium. Trials
9.23.22
6 min. Read
Digital health benefits stacks: Hitachi and Western Digital
9.21.22
7 min. Read
Big Health RCT suggests Sleepio heading to FDA? Trials
9.16.22
8 min. Read
About $120 million in secret health tech deals
9.12.22
4 min. Read
Apple hints about future FDA submissions. Trial updates
9.09.22
8 min. Read
Mahana’s freemium prescription digital therapeutic.
9.02.22
6 min. Read
Funding scoops: Recuro Health, January AI and more
8.29.22
4 min. Read
  • First
  • Previous
  • 1 of 27
  • Next
  • Last